Diego Cortina

Company: Biogen

Job title: Director, Global Pipeline & Value Evidence Strategy

Bio:

Diego Cortina is a global market access and pricing executive with over 20 years of leadership experience in the pharmaceutical and biotechnology industry. He has held senior roles at companies including Biogen, Novartis, Bayer, and Abbott, driving access, pricing, and launch strategies across the U.S., Europe, and Latin America.

Currently serving as Director of Pipeline Global Market Access Strategy at Biogen, Diego leads access planning for early-phase assets in neurology and rare diseases, providing strategic input into payer research, trial design, and go/no-go decisions. He has played a key role in the global commercialization of multiple sclerosis therapies, including the successful launch of Vumerity and the NRDL listing of Tecfidera in China.

Throughout his career, Diego has built strong partnerships with payers, regulators, and patient organizations, combining strategic insight with a deep commitment to public health. He has negotiated risk-sharing agreements, led regional advocacy campaigns, and authored policy-focused publications.

Diego holds a Doctor of Medicine from Universidad Anáhuac México Norte and a Master’s in Health Policy Planning & Financing from the London School of Economics and the London School of Hygiene and Tropical Medicine. He is fluent in English, Spanish, and Portuguese and is based in New Jersey.

Seminars:

Designing Fair & Flexible Compensation Models to Maximize Trial Participation 3:15 pm

Assessing patient financial burdens beyond travel, childcare, lost wages, and more The voice of the patient and caregiver as critical factor in shaping clinical meaningful endpoint selection Balancing ethical considerations with practical incentives to encourage participation Collaborating with payers and regulators to ensure compliance, transparency, and meaningful outcomesRead more

day: Day Two